Coppell Advisory Solutions LLC Blueprint Medicines Corp Transaction History
Coppell Advisory Solutions LLC
- $716 Billion
- Q4 2024
A detailed history of Coppell Advisory Solutions LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Coppell Advisory Solutions LLC holds 462 shares of BPMC stock, worth $44,615. This represents 0.01% of its overall portfolio holdings.
Number of Shares
462
Previous 436
5.96%
Holding current value
$44,615
Previous $40.4 Million
0.6%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding BPMC
# of Institutions
380Shares Held
65.9MCall Options Held
1.6MPut Options Held
1.41M-
Vanguard Group Inc Valley Forge, PA6.77MShares$654 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$642 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.68MShares$548 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA4.28MShares$413 Million0.07% of portfolio
-
State Street Corp Boston, MA2.5MShares$241 Million0.01% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $5.77B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...